Cardiometabolic, Cardiovascular Complications Less Likely With Hydroxychloroquine in DLE

Follow Drugslib on

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on June 3, 2026.

via HealthDay

WEDNESDAY, June 3, 2026 -- Hydroxychloroquine (HCQ) treatment for discoid lupus erythematosus (DLE) is associated with a lower risk for developing cardiovascular and cardiometabolic complications, according to a study published online April 17 in the Journal of the American Academy of Dermatology.

Anjana Srikumar, from Johns Hopkins University School of Medicine in Baltimore, and colleagues evaluated whether HCQ initiation in adults with isolated DLE is associated with lower five-year cardiometabolic and cardiovascular risk. The analysis included 106 adults with isolated DLE from a single center (including 60 HCQ users), as well as 2,260 propensity-matched pairs with isolated DLE, identified from the TriNetX database, who were matched based on HCQ use or no use.

The researchers found that in the single-center cohort, HCQ use was associated with a significantly lower likelihood of developing hyperlipidemia (23.3 versus 47.8 percent), peripheral artery disease (1.7 versus 17.4 percent), angina (3.3 versus 26.1 percent), and coronary artery disease (CAD; 10.0 versus 26.1 percent), regardless of DLE extent. In the TriNetX cohort, HCQ use was associated with a significantly lower risk for hypertension (14.1 versus 17.3 percent), hyperlipidemia (8.4 versus 15.1 percent), type 2 diabetes (4.3 versus 6.3 percent), stroke (1.0 versus 2.3 percent), and CAD (4.2 versus 5.9 percent).

"All patients with skin lupus will benefit if we can shift broader clinical perspectives of the disease and develop clear guidelines that address how it harms health beyond the skin," senior author Jun Kang, M.D., also from Johns Hopkins, said in a statement.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-06-04 03:51

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords